CoChat

Is the Prevalence of Addison's Disease Underestimated?

Laureti, S. · 1999 · Journal of Clinical Endocrinology & Metabolism
Cited by 212

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The clinical spectrum of Addison’s disease has changed dramatically over the last 30 years, and autoimmunity is now the most common cause of primary adrenal insufficiency in Western countries (1). Using an original flowchart of immune and biochemical markers, we have shown that adrenal autoantibodies are present in 70% of Addison patients (2). Furthermore, approximately 1% of patients with endocrine autoimmune disorders have clinical or subclinical signs of adrenal insufficiency (3). In spite of the availability of accurate biochemical and immune markers of Addison’s disease, its prevalence in the general population has not been widely investigated. In initial studies (4, 5), the prevalence of Addison’s disease in Western countries was calculated at 35–60 per million. However, the results of a recent study (6) suggest that this disease could be more common than previously reported. To accurately evaluate the prevalence of Addison’s disease in the general population, we selected a geographically delimited region of central Italy, Umbria, and we determined the total number of subjects suffering from Addison’s disease, during the period January 1–December 31, 1996 in this region. According to the Italian Institute of Statistics (ISTAT), the population resident in Umbria is 811,887 (394,211 males and 417,676 females). We used the clinical records of the patients attending the endocrine unit of our department as the primary data source. Because cortisone acetate is the only treatment for Addison’s disease available in Italy, given the unavailability of oral preparations of hydrocortisone, we used the regional computerized file of the prescriptions of cortisone acetate as a secondary and independent source. Diagnosis of Addison’s disease was confirmed by interviewing the treating physicians and by following standard criteria (1). The primary source identified 59 Addison patients and the secondary source 234 subjects in treatment with cortisone acetate. Of these latter 234 subjects, 91 had Addison’s disease, and 55 of them had already been identified by the primary source. The remaining 143 subjects identified by the secondary source had either secondary adrenal insufficiency or a neoplasm impairing adrenal function. Overall, the two data sources identified a total of 95 (42 males and 53 females) Addison patients, and the combined case ascertainment was 97% as calculated by capture-recapture analysis. The resulting prevalence of Addison’s disease in the general population was 117 per million (95% confidence interval: 95–143). Prevalence among males and females was 106 per million (95% confidence interval: 77–144) and 127 per million (95% confidence interval: 95–166), respectively. The frequency of Addison’s disease in our study represents the highest prevalence reported so far, and it is 2- to 3-fold higher than those previously reported in other studies (4, 5). Our results indicate that the prevalence of Addison’s disease has so far been underestimated. Given the increase in frequency of adrenal autoimmunity in Addison patients observed over the last 20 years, we hypothesize that the incidence and prevalence of autoimmune adrenal insufficiency is rising. Additional population-based studies are needed to monitor the yearly incidence of this disease and to test this latter specific hypothesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.84.5.1762

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 212

Metadata

Authors
Laureti, S.
Venue
Journal of Clinical Endocrinology & Metabolism
Published
1999-05-01
Volume
84
Issue
5
Pages
1762-1762
ISSN
0021-972X (ISSN-L)
OpenAlex
W2078574865
Cited by
212
References
1
FWCI
4.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is the Prevalence of Addison's Disease Underestimated? https://app.cochat.ai/papers/10.1210/jc.84.5.1762
The paper
Laureti, S. (1999). Is the Prevalence of Addison's Disease Underestimated? Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.84.5.1762

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.